Recent Trends in Breast, Cervical, and Colorectal Cancer Screening Test Utilization in Canada, Using Self-Reported Data from 2008 and 2012

Current Oncology - Tập 22 Số 4 - Trang 297-302
Diane Major1,2, David Armstrong3, Heather Bryant1,4, Winson Y. Cheung5, Kathleen Decker6, Gregory Doyle7, V. Mai1, C. Meg McLachlin8, Jin Niu1, Jennifer Payne9, N. K. Shukla1
1Canadian Partnership against Cancer, Toronto, ON, Canada
2Département médecine sociale et préventive, Université Laval, Quebec, QC, Canada
3Division of Gastroenterology, McMaster University Medical Centre, Hamilton, ON, Canada
4Departments of Community Health Sciences and Oncology, University of Calgary, Calgary, AB, Canada
5Division of Medical Oncology, BC Cancer Agency, and Department of Medicine, University of British Columbia, Vancouver, BC, Canada
6Cancercare Manitoba and University of Manitoba, Winnipeg, MB, Canada
7Breast Screening Program for Newfoundland and Labrador, St. John's, NL, Canada
8Department of Pathology and Laboratory Medicine Western University, London, ON, Canada
9Department of Diagnostic Radiology, Dalhousie University, and Nova Scotia Breast Screening Program, Halifax, NS, Canada

Tóm tắt

In Canada, self-reported data from the Canadian Community Health Survey 2008 and 2012 provide an opportunity to examine overall utilization of breast, cervical, and colorectal cancer screening tests for both programmatic and opportunistic screening. Among women 50–74 years of age, utilization of screening mammography was stable (62.0% in 2008 and 63.0% in 2012). Pap test utilization for women 25–69 years of age remained high and stable across Canada in 2008 and 2012 (78.9% in 2012). The percentage of individuals 50–74 years of age who reporting having at least 1 fecal test within the preceding 2 years increased in 2012 (to 23.0% from 16.9% in 2008), but remains low. Stable rates of screening mammography utilization (about 30%) were reported in 2008 and 2012 among women 40–49 years of age, a group for which population-based screening is not recommended. Although declining over time, cervical cancer screening rates were high for women less than 25 years of age (for whom screening is not recommended). Interestingly, an increased percentage of women 70–74 years of age reported having a Pap test. In 2012, a smaller percentage of women 50–69 years of age reported having no screening test (5.9% vs. 8.5% in 2008), and more women reported having the three types of cancer screening tests (19.0% vs. 13.2%). Efforts to encourage use of screening within the recommended average-risk age groups are needed, and education for stakeholders about the possible harms of screening outside those age groups has to continue.

Từ khóa


Tài liệu tham khảo

Thông tin
Thông tin xuất bản

Current Oncology

Tập 22 Số 4

297-302

Thông tin tác giả